Report Detail
COVID-19 Impact on Global Angiotensin II Receptor Blockers Market Insights, Forecast to 2026
- RnM4018792 |
- 09 June, 2020 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Angiotensin II Receptor Blockers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin II Receptor Blockers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Angiotensin II Receptor Blockers market is segmented into
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Segment by Application, the Angiotensin II Receptor Blockers market is segmented into
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
Regional and Country-level Analysis
The Angiotensin II Receptor Blockers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Angiotensin II Receptor Blockers market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Angiotensin II Receptor Blockers Market Share Analysis
Angiotensin II Receptor Blockers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiotensin II Receptor Blockers business, the date to enter into the Angiotensin II Receptor Blockers market, Angiotensin II Receptor Blockers product introduction, recent developments, etc.
The major vendors covered:
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
1 Study Coverage
- 1.1 Angiotensin II Receptor Blockers Product Introduction
- 1.2 Market Segments
- 1.3 Key Angiotensin II Receptor Blockers Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Angiotensin II Receptor Blockers Market Size Growth Rate by Type
- 1.4.2 Azilsartan
- 1.4.3 Candesartan
- 1.4.4 Eprosartan
- 1.4.5 Irbesartan
- 1.4.6 Losartan
- 1.4.7 Olmesartan
- 1.4.8 Telmisartan
- 1.4.9 Valsartan
- 1.5 Market by Application
- 1.5.1 Global Angiotensin II Receptor Blockers Market Size Growth Rate by Application
- 1.5.2 Chronic Kidney Diseases
- 1.5.3 Heart Failure
- 1.5.4 Kidney Failure in Diabetes
- 1.6 Coronavirus Disease 2019 (Covid-19): Angiotensin II Receptor Blockers Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Angiotensin II Receptor Blockers Industry
- 1.6.1.1 Angiotensin II Receptor Blockers Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Angiotensin II Receptor Blockers Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Angiotensin II Receptor Blockers Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Angiotensin II Receptor Blockers Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Angiotensin II Receptor Blockers Market Size Estimates and Forecasts
- 2.1.1 Global Angiotensin II Receptor Blockers Revenue 2015-2026
- 2.1.2 Global Angiotensin II Receptor Blockers Sales 2015-2026
- 2.2 Angiotensin II Receptor Blockers Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Angiotensin II Receptor Blockers Competitor Landscape by Players
- 3.1 Angiotensin II Receptor Blockers Sales by Manufacturers
- 3.1.1 Angiotensin II Receptor Blockers Sales by Manufacturers (2015-2020)
- 3.1.2 Angiotensin II Receptor Blockers Sales Market Share by Manufacturers (2015-2020)
- 3.2 Angiotensin II Receptor Blockers Revenue by Manufacturers
- 3.2.1 Angiotensin II Receptor Blockers Revenue by Manufacturers (2015-2020)
- 3.2.2 Angiotensin II Receptor Blockers Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Angiotensin II Receptor Blockers Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Angiotensin II Receptor Blockers Revenue in 2019
- 3.2.5 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Angiotensin II Receptor Blockers Price by Manufacturers
- 3.4 Angiotensin II Receptor Blockers Manufacturing Base Distribution, Product Types
- 3.4.1 Angiotensin II Receptor Blockers Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angiotensin II Receptor Blockers Product Type
- 3.4.3 Date of International Manufacturers Enter into Angiotensin II Receptor Blockers Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Angiotensin II Receptor Blockers Market Size by Type (2015-2020)
- 4.1.1 Global Angiotensin II Receptor Blockers Sales by Type (2015-2020)
- 4.1.2 Global Angiotensin II Receptor Blockers Revenue by Type (2015-2020)
- 4.1.3 Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Angiotensin II Receptor Blockers Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Angiotensin II Receptor Blockers Sales Forecast by Type (2021-2026)
- 4.2.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Type (2021-2026)
- 4.2.3 Angiotensin II Receptor Blockers Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Angiotensin II Receptor Blockers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Angiotensin II Receptor Blockers Market Size by Application (2015-2020)
- 5.1.1 Global Angiotensin II Receptor Blockers Sales by Application (2015-2020)
- 5.1.2 Global Angiotensin II Receptor Blockers Revenue by Application (2015-2020)
- 5.1.3 Angiotensin II Receptor Blockers Price by Application (2015-2020)
- 5.2 Angiotensin II Receptor Blockers Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Angiotensin II Receptor Blockers Sales Forecast by Application (2021-2026)
- 5.2.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Angiotensin II Receptor Blockers Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Angiotensin II Receptor Blockers by Country
- 6.1.1 North America Angiotensin II Receptor Blockers Sales by Country
- 6.1.2 North America Angiotensin II Receptor Blockers Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Angiotensin II Receptor Blockers Market Facts & Figures by Type
- 6.3 North America Angiotensin II Receptor Blockers Market Facts & Figures by Application
7 Europe
- 7.1 Europe Angiotensin II Receptor Blockers by Country
- 7.1.1 Europe Angiotensin II Receptor Blockers Sales by Country
- 7.1.2 Europe Angiotensin II Receptor Blockers Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Type
- 7.3 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Angiotensin II Receptor Blockers by Region
- 8.1.1 Asia Pacific Angiotensin II Receptor Blockers Sales by Region
- 8.1.2 Asia Pacific Angiotensin II Receptor Blockers Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Type
- 8.3 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Angiotensin II Receptor Blockers by Country
- 9.1.1 Latin America Angiotensin II Receptor Blockers Sales by Country
- 9.1.2 Latin America Angiotensin II Receptor Blockers Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Angiotensin II Receptor Blockers Market Facts & Figures by Type
- 9.3 Central & South America Angiotensin II Receptor Blockers Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Angiotensin II Receptor Blockers by Country
- 10.1.1 Middle East and Africa Angiotensin II Receptor Blockers Sales by Country
- 10.1.2 Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Type
- 10.3 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck & Co.
- 11.1.1 Merck & Co. Corporation Information
- 11.1.2 Merck & Co. Description, Business Overview and Total Revenue
- 11.1.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered
- 11.1.5 Merck & Co. Recent Development
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Corporation Information
- 11.2.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 AstraZeneca Angiotensin II Receptor Blockers Products Offered
- 11.2.5 AstraZeneca Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Corporation Information
- 11.3.2 Novartis Description, Business Overview and Total Revenue
- 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novartis Angiotensin II Receptor Blockers Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Teva
- 11.4.1 Teva Corporation Information
- 11.4.2 Teva Description, Business Overview and Total Revenue
- 11.4.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Teva Angiotensin II Receptor Blockers Products Offered
- 11.4.5 Teva Recent Development
- 11.5 Bayer
- 11.5.1 Bayer Corporation Information
- 11.5.2 Bayer Description, Business Overview and Total Revenue
- 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Bayer Angiotensin II Receptor Blockers Products Offered
- 11.5.5 Bayer Recent Development
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Corporation Information
- 11.6.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Products Offered
- 11.6.5 GlaxoSmithKline Recent Development
- 11.7 Sun Pharmaceutical
- 11.7.1 Sun Pharmaceutical Corporation Information
- 11.7.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
- 11.7.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Products Offered
- 11.7.5 Sun Pharmaceutical Recent Development
- 11.8 Mylan
- 11.8.1 Mylan Corporation Information
- 11.8.2 Mylan Description, Business Overview and Total Revenue
- 11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Mylan Angiotensin II Receptor Blockers Products Offered
- 11.8.5 Mylan Recent Development
- 11.1 Merck & Co.
- 11.1.1 Merck & Co. Corporation Information
- 11.1.2 Merck & Co. Description, Business Overview and Total Revenue
- 11.1.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered
- 11.1.5 Merck & Co. Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Angiotensin II Receptor Blockers Market Estimates and Projections by Region
- 12.1.1 Global Angiotensin II Receptor Blockers Sales Forecast by Regions 2021-2026
- 12.1.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Regions 2021-2026
- 12.2 North America Angiotensin II Receptor Blockers Market Size Forecast (2021-2026)
- 12.2.1 North America: Angiotensin II Receptor Blockers Sales Forecast (2021-2026)
- 12.2.2 North America: Angiotensin II Receptor Blockers Revenue Forecast (2021-2026)
- 12.2.3 North America: Angiotensin II Receptor Blockers Market Size Forecast by Country (2021-2026)
- 12.3 Europe Angiotensin II Receptor Blockers Market Size Forecast (2021-2026)
- 12.3.1 Europe: Angiotensin II Receptor Blockers Sales Forecast (2021-2026)
- 12.3.2 Europe: Angiotensin II Receptor Blockers Revenue Forecast (2021-2026)
- 12.3.3 Europe: Angiotensin II Receptor Blockers Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Angiotensin II Receptor Blockers Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Angiotensin II Receptor Blockers Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Angiotensin II Receptor Blockers Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Angiotensin II Receptor Blockers Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Angiotensin II Receptor Blockers Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Angiotensin II Receptor Blockers Sales Forecast (2021-2026)
- 12.5.2 Latin America: Angiotensin II Receptor Blockers Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Angiotensin II Receptor Blockers Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Angiotensin II Receptor Blockers Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Angiotensin II Receptor Blockers Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Angiotensin II Receptor Blockers Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Angiotensin II Receptor Blockers Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Angiotensin II Receptor Blockers Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angiotensin II Receptor Blockers Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Angiotensin II Receptor Blockers. Industry analysis & Market Report on COVID-19 Impact on Global Angiotensin II Receptor Blockers is a syndicated market report, published as COVID-19 Impact on Global Angiotensin II Receptor Blockers Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Angiotensin II Receptor Blockers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
